Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Squadron Capital Management LLC
Form 13F · Q2 2026

Squadron Capital Management LLC

CIK 2050709申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$3.2亿
申報組合市值
43
持倉數量
3
Quarters on record
Top 50
持倉數量

Squadron Capital Management LLC——持倉

共 43 個持倉中的前 34 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1RLMD Relmada Therapeutics Inc7.3M−13.3%$5086万15.8%
2CCCC C4 Therapeutics Inc7.2M+220.0%$3362万10.4%
3COGT Cogent Biosciences Inc865,000+9.8%$3348万10.4%
4KOD Kodiak Sciences Inc500,000+31.6%$1948万6.0%
5RLAY Relay Therapeutics Inc970,000+44.2%$1815万5.6%
6ZNTL Zentalis Pharmaceuticals Inc3.7M+1.9%$1794万5.6%
7EWTX Edgewise Therapeutics Inc290,000−17.1%$1178万3.7%
8MAZE Maze Therapeutics Inc335,000+30.1%$1000万3.1%
9IVA Inventiva Sa2.4M+355.1%$920万2.9%
10ANL Adlai Nortye Ltd764,876−39.5%$880万2.7%
11ELVN Enliven Therapeutics Inc160,000—$812万2.5%
12PALI Palisade Bio Inc3.0M+0.0%$627万1.9%
13IKT Inhibikase Therapeutics Inc3.0M−14.3%$609万1.9%
14ADAG Adagene Inc1.2M—$525万1.6%
15FORTE BIOSCIENCES INC Forte Biosciences Inc225,000—$478万1.5%
16IFRX Inflarx Nv2.0M—$448万1.4%
17ASMB Assembly Biosciences Inc160,000—$440万1.4%
18PMN Promis Neurosciences Inc324,977+0.0%$428万1.3%
19CTNM Contineum Therapeutics Inc260,000—$426万1.3%
20CMPS Compass Pathways Plc300,000—$424万1.3%
21DFTX Definium Therapeutics Inc85,000—$400万1.2%
22SLGL Sol-Gel Technologies Ltd52,000+67.7%$386万1.2%
23BIOA Bioage Labs Inc155,000—$380万1.2%
24SCYX Scynexis Inc756,884—$308万1.0%
25PRQR Proqr Thrapeutics N V1.5M—$281万0.9%
26RZLT Rezolute Inc403,410—$210万0.7%
27LPCN Lipocine Inc New810,000+80.0%$207万0.6%
28CUE Cue Biopharma Inc50,000—$158万0.5%
29CALC Calcimedica Inc1.2M—$128万0.4%
30QUINCE THERAPEUTICS INC Quince Therapeutics Inc40,375—$73万0.2%
31KTTA Pasithea Therapeutics Corp1.0M−52.4%$52万0.2%
32MTRI Inmed Pharmaceuticals Inc325,000—$50万0.2%
33NMRA Neumora Therapeutics Inc.100,000—$17万0.1%
34NXTC Nextcure Inc64,464−75.7%$10万0.0%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。